Journal article
Friedreich ataxia clinical outcome measures: Natural history evaluation in 410 participants
SR Regner, NS Wilcox, LS Friedman, LA Seyer, KA Schadt, KW Brigatti, S Perlman, M Delatycki, GR Wilmot, CM Gomez, KO Bushara, KD Mathews, SH Subramony, T Ashizawa, B Ravina, A Brocht, JM Farmer, DR Lynch
Journal of Child Neurology | Published : 2012
Abstract
Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by ataxia, dysarthria, and areflexia. The authors report the progress of a large international noninterventional cohort (n = 410), tracking the natural history of disease progression using the neurologic examination-based Friedreich Ataxia Rating Scale. The authors analyzed the rate of progression with cross-sectional analysis and longitudinal analysis over a 2-year period. The Friedreich Ataxia Rating Scale captured disease progression when used at 1 and 2 years following initial evaluation, with a lower ratio of standard deviation of change to mean change over 2 years of evaluation. However, modeling of di..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was supported by grants from the Muscular Dystrophy Association and the Friedreich Ataxia Research Alliance. Supported by grants from the National Institutes of Health (2R13NS040925-14 Revised), the National Institutes of Health Office of Rare Diseases Research, the Child Neurology Society, and the National Ataxia Foundation.